MIEN1 and prostate carcinoma: On the contrary, since MIEN1 is differentially expressed between normal and cancer cells and tissues, deciphering the regulatory mechanism(s) that explain the aberrant expression of MIEN1 in cancer will enable targeting MIEN1 using mechanisms that are endogenously prevalent thus forming an intervention for prostate cancer progression.